돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 869556생성일: 2026년 10월 25일

2-cyclopropyl-1H-1,3-benzodiazole → (E)-2-cyclopropyl-2-{8-[(2-cyclopropyl-1H-benzo[d]imidazol-1-yl)methyl]-3-fluorodibenzo[b,e]oxepin-11(6H)-ylidene)acetonitrile

https://huagongshe.com/reaction/869556

반응식

참여 물질

역할이름HCID투입량
반응물2-cyclopropyl-1H-1,3-benzodiazoleHCID 1084419—
반응물(E)-2-(8-bromomethyl-3-fluorodibenzo[b,e]oxepin-11(6H)-ylidene)-2-cyclopropylacetonitrileHCID 86721388—
생성물(E)-2-cyclopropyl-2-{8-[(2-cyclopropyl-1H-benzo[d]imidazol-1-yl)methyl]-3-fluorodibenzo[b,e]oxepin-11(6H)-ylidene)acetonitrileHCID 8672138993%

반응 단계

Using 2-cyclopropyl-1H-benzo[d]imidazole (European Journal of Organic Chemistry, 2000, p 1229, 58 mg, 0.33 mmol) and (E)-2-(8-bromomethyl-3-fluorodibenzo[b,e]oxepin-11(6H)-ylidene)-2-cyclopropylacetonitrile (120 mg, 0.31 mmol) obtained in Reference Example 6, and in the same manner as in Reference Example 1A, the title compound (133 mg, 93%) was obtained.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08969345B2
출처 데이터셋uspto-grants-2015_03
ORD IDord-e84a5c4544914eeeaaae9a742f8fa1e5
출처 메모uspto-grants-2015_03